TABLE 4.
Comparison of laboratory examination results and PDGF‐BB levels among control group, SAP group, and ACS group
| Control group (n = 86) | SAP group (n = 79) | ACS group (n = 134) | F/Z | p | |
|---|---|---|---|---|---|
| Glu (mmol/L) | 5.50 ± 1.09 | 5.70 ± 1.53 | 5.69 ± 1.45 | 0.667 | 0.514 |
| TC (mmol/L) | 4.62 ± 1.13 | 4.50 ± 0.89 | 4.63 ± 1.29 | 0.360 | 0.698 |
| TG (mmol/L) | 1.58 ± 0.85 | 1.88 ± 1.34 | 1.85 ± 1.50 | 1.559 | 0.212 |
| HDLc (mmol/L) | 1.16 ± 0.33 | 1.01 ± 0.25Δ | 1.06 ± 0.46 | 3.554 | 0.030* |
| LDLc (mmol/L) | 2.88 ± 0.91 | 2.80 ± 0.81 | 2.92 ± 1.10 | 0.349 | 0.706 |
| WBC (×109/L) | 6.39 ± 1.49 | 6.49 ± 1.57 | 6.76 ± 1.50 | 1.938 | 0.146 |
| Plt (×109/L) | 234.25 ± 54.07 | 222.78 ± 55.04 | 231.48 ± 56.14 | 1.016 | 0.363 |
| hsCRP (mg/L) | 0.83 (0.44, 2.32) | 1.02 (0.49, 2.42) | 1.44 (0.75, 3.91)ab | 10.653 | 0.005** |
| PDGF‐BB (pg/ml) | 224.10 ± 111.83 | 231.00 ± 134.50 | 271.98 ± 129.62ab | 5.262 | 0.006** |
Note: The measurement data (Glu, TC, TG, HDLc, LDLc, WBC, Plt) were shown by mean ± SD, and those among control group, SAP group, and ACS group were analyzed by univariate ANOVA (*p < 0.05, **p < 0.01). The data of hsCRP level that did not match normal distribution were expressed as median and quartile M (P25, P75), that among three groups was analyzed by nonparametric Kruskal–Wallis univariate ANOVA test (*p < 0.05, **p < 0.01). The pairwise comparison was analyzed by q test (Δ compared with control group p < 0.05; Superscript letter a compared with control group, p < 0.01; Superscript letter b compared with SAP group, p < 0.01).
Abbreviations: ACS, acute coronary syndrome; CHD, coronary heart disease; Glu, Glucose; HDLc, high‐density lipoprotein cholesterol; hsCRP, high sensitivity C‐reactive protein; LDLc, low‐density lipoprotein cholesterol; PDGF‐BB, platelet‐derived growth factor‐BB; Plt, blood platelet; SAP, stable angina pectoria; TC, total cholesterol; TG, triglyceride; WBC, white blood cells.